Vir Biotechnology is investing in cures, treatments, and preventions for challenging viral and bacterial diseases, including those caused by drug-resistant bacteria and emerging pathogens. The company was created by ARCH Venture Partners and will be supported by a diverse consortium of long-term investors, including the Bill & Melinda Gates Foundation, sovereign wealth funds, public mutual funds, and prominent individuals and family offices.

Key Contact